lithium has been researched along with Acquired Nephrogenic Diabetes Insipidus in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (14.71) | 18.2507 |
2000's | 20 (29.41) | 29.6817 |
2010's | 21 (30.88) | 24.3611 |
2020's | 17 (25.00) | 2.80 |
Authors | Studies |
---|---|
Sancak, EB; Tas, HI | 1 |
Chandrasekaran, PK; O Brien, FM; Yan Qi, OW | 1 |
Bae, EH; Choi, HS; Goo, YJ; Kim, CS; Kim, M; Kim, SW; Kwon, OI; Ma, SK; Oh, TR; Song, SH; Suh, SH | 1 |
Danilowicz, K; Deligiannis, NG; León, NS; Lerena, VS; Rizzo, LFL; Sosa, S | 1 |
Haissaguerre, M; Vantyghem, MC | 1 |
Bodenstein, K; Damba, JJ; Drury, J; Greenway, KT; Lavin, P; Rej, S; Renoux, C; Sekhon, H; Trinh, E | 1 |
Bouquegneau, A; Delanaye, P; Forte, F; Tiv, H; Vandelaer, A | 1 |
Farmand, F; Kawashita, T; Li, JJ; Tagle, CA; Tan, S | 1 |
Vantyghem, MC | 1 |
D'Agostino, M; Login, FH; Nejsum, LN; Nørregaard, R; Tamma, G; Tingskov, SJ | 1 |
Deng, M; Dou, X; Guo, X; Jia, Z; Li, X; Liang, A; Liu, M; Luo, Q; Luo, X; Mo, M; Pan, J; Sun, P; Zhang, W | 1 |
Echater, S; Hasnaoui, M; Lechner, E | 1 |
Hyer, S; Johri, N; Nandoshvili, E | 1 |
Emlet, DR; Hahn, S; Jobbagy, S; Pires, MF; Ross, M; Rowart, P; Salvatore, SR; Schopfer, FJ; St Croix, C; Straub, AC; Subramanya, AR; Tan, RJ; Vitturi, DA; Wendell, SG | 1 |
Beaulieu, S; Cervantes, P; Christensen, BM; D'Apolito, L; Dols, A; Fotso Soh, J; Herrmann, N; Levinson, A; Linnaranta, O; Low, N; Mucsi, I; Müller, D; Mulsant, BH; Platt, RW; Rajji, T; Rej, S; Renaud, S; Saury, S; Schaffer, A; Su, CL; Torres-Platas, G; Trepiccione, F | 1 |
Inoue, M; Mitsuiki, K; Nakai, K | 1 |
Figueiredo, C; Lemos, J | 1 |
Baumgarten, R; Bressers, S; Damen, L; de Groot, T; Deen, PMT; Doty, R; Korstanje, R; Kraak, J | 1 |
Kattah, AG; Pawar, AS | 1 |
Carlson, NG; Hansson, KM; Huang, Y; Kishore, BK; Liu, T; Magnell, K; Zhang, Y | 1 |
Looper, K; Rej, S; Segal, M; Senouci, SI | 1 |
Capasso, G; Christensen, BM; Nielsen, S; Trepiccione, F | 1 |
Brooks, HL; Cai, Q; Gao, Y; Price, TJ; Romero-Aleshire, MJ | 1 |
Adlan, MA; Govindan, J; Kamath, C; Premawardhana, AD; Premawardhana, LD; Wood, SJ | 1 |
Baumgarten, R; de Groot, T; Deen, PM; Devuyst, O; Kortenoeven, ML; Loffing, J; Sinke, AP; Wetzels, JF | 1 |
Dong, Z; Livingston, MJ | 1 |
Alsady, M; Baumgarten, R; de Groot, T; Deen, PM; Giles, RH; Jaklofsky, M; Otte-Höller, I | 1 |
Razzak, M | 1 |
Giuliani, C; Peri, A | 1 |
Black, LN; Blount, MA; Himmel, NJ; Hong, SM; Pulous, FE; Redd, SK; Rogers, RT; Sim, JH; von Bergen, TN | 1 |
Baqi, Y; Carlson, NG; Heiney, KM; Kishore, BK; Kohan, DE; Müller, CE; Peti-Peterdi, J; Strasburg, DL; Villanueva, K; Zhang, Y | 1 |
Carlson, NG; Ecelbarger, CM; Kishore, BK; Kohan, DE; Müller, CE; Nelson, RD; Peti-Peterdi, J; Zhang, Y | 1 |
Do, A; Elie, D; Herrmann, N; Looper, KJ; Marshe, V; Müller, DJ; Pira, S; Rej, S | 1 |
Feng, P; Hu, S; Li, C; Liang, X; Lin, Y; Luo, R; Wang, F; Wang, W; Zhang, T; Zheng, P | 1 |
Feng, P; Kong, Y; Levi, M; Li, C; Li, S; Lin, Y; Liu, Q; Qiu, M; Wang, W; Zhang, T; Zheng, P | 1 |
Carlson, NG; Kamerath, CD; Kishore, BK; Kohan, DE; Nelson, RD; Zhang, Y | 1 |
Deen, PM; Gaeggeler, HP; Kortenoeven, ML; Li, Y; Rossier, BC; Shaw, S; Wetzels, JF | 1 |
To, TH | 1 |
Baek, MC; Choi, HJ; Frøkiær, J; Jung, HJ; Kwon, TH; Lee, JE; Lee, YJ; Lim, JS; Nielsen, S | 1 |
Galizia, L; Kotsias, BA; Marino, GI | 1 |
Mason, B; Utter, G; Vengalil, S; Yingling, DR | 1 |
Frøkiaer, J; Kim, YH; Knepper, MA; Kwon, TH; Nielsen, J; Nielsen, S; Praetorius, J | 1 |
Christensen, BM; Frøkiaer, J; Kim, YH; Kwon, TH; Madsen, KM; Nielsen, J; Nielsen, S; Wall, SM | 1 |
Christensen, BM; Frøkiaer, J; Kim, YH; Marples, D; Nielsen, S; Wang, W | 1 |
Kwon, TH; Laursen, UH; Maunsbach, AB; Nielsen, S; Pihakaski-Maunsbach, K; Østergaard Jensen, E | 1 |
Chang, HR; Earm, JH; Han, JS; Joo, KW; Kim, GH; Knepper, MA; Lee, JW; Na, KY; Oh, YK | 1 |
Frøkiaer, J; Kotnik, P; Krzisnik, C; Kwon, TH; Nielsen, J; Nielsen, S | 1 |
Clark, WF; Garg, AX; Garofeanu, CG; Henson, G; Rosas-Arellano, MP; Weir, M | 1 |
Hasan, A; Imam, SK; Shahid, SK | 1 |
Frøkiaer, J; Knepper, MA; Kwon, TH; Nielsen, J; Nielsen, S | 1 |
Deen, PM; Kamsteeg, EJ; Li, Y; Shaw, S; Vandewalle, A | 1 |
Boer, WH; van Gerven, HA | 2 |
Bedford, JJ; Jing, R; Klein, JD; Leader, JP; Sands, JM; Walker, LJ; Walker, RJ | 1 |
Agre, P; Fenton, RA; Hoffert, JD; Knepper, MA; Nielsen, J; Nielsen, S | 1 |
Jefferson, JW | 1 |
Matz, R | 1 |
Allen, A; Forni, L; Hilton, P; Wright, D | 1 |
Swaminathan, R | 1 |
Christensen, EI; Christensen, S; Marples, D; Nielsen, S; Ottosen, PD | 1 |
Golembiewski, GH; Johnson, MA; Ogorman, J; Paluzzi, MW | 1 |
Kjellstrand, C; Lam, SS | 1 |
Donders, SH; Meinardi, JR | 1 |
Baylis, PH; France, AJ; Thompson, CJ | 1 |
Arfi, C; Blanchard, A; Farge, D; Houiller, P; Leviel, F; Paillard, M | 1 |
Aurell, M; Bendz, H; Lanke, J | 1 |
Gokulkrishnan, L; Mohanaruban, K; Mukhopadhyay, D | 1 |
Christensen, S; Janjua, NR; Jonassen, TE; Langhoff, S; Thomsen, K | 1 |
8 review(s) available for lithium and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
What an endocrinologist should know for patients receiving lithium therapy.
Topics: Calcium; Diabetes Insipidus, Nephrogenic; Endocrinologists; Female; Goiter; Humans; Hypercalcemia; Hyperparathyroidism; Lithium; Lithium Compounds | 2022 |
Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Diabetes Insipidus, Nephrogenic; Female; Humans; Kidney; Lithium; Lithium Compounds; Psychotropic Drugs; Renal Insufficiency, Chronic; Valproic Acid | 2022 |
Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Body Water; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Demeclocycline; Diabetes Insipidus, Nephrogenic; Disease Management; Drug Interactions; Hospitalization; Humans; Hydrocortisone; Hyponatremia; Hypothyroidism; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium; Multicenter Studies as Topic; Osmolar Concentration; Paraneoplastic Syndromes; Saline Solution, Hypertonic; Tolvaptan | 2014 |
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Humans; Lithium; Natriuresis; Receptors, Purinergic P2Y2 | 2015 |
Molecular mechanisms in lithium-associated renal disease: a systematic review.
Topics: Animals; Aquaporins; Calcium; Diabetes Insipidus, Nephrogenic; Humans; Lithium; Prostaglandins; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Signal Transduction; Sodium; Symporters; Vasopressins | 2016 |
Causes of reversible nephrogenic diabetes insipidus: a systematic review.
Topics: Anti-Infective Agents; Antineoplastic Agents; Cohort Studies; Cross-Sectional Studies; Diabetes Insipidus, Nephrogenic; Humans; Hypercalcemia; Kidney; Lithium; Metabolic Diseases; Risk Factors | 2005 |
[Chronic renal function disorders during lithium use].
Topics: Bipolar Disorder; Depressive Disorder; Diabetes Insipidus, Nephrogenic; Humans; Kidney Failure, Chronic; Lithium; Risk Factors | 2006 |
Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diabetes Insipidus, Nephrogenic; Female; Humans; Indomethacin; Lithium; Middle Aged; Psychotic Disorders; Sodium | 1997 |
1 trial(s) available for lithium and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atorvastatin; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Lithium; Middle Aged; Pilot Projects; Young Adult | 2021 |
59 other study(ies) available for lithium and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats.
Topics: Animals; Aquaporin 2; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus, Type 2; Humans; Lithium; Metformin; Rats | 2021 |
The cascade to a serendipitous discovery of lithium-induced nephrogenic diabetes insipidus.
Topics: Aged; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Female; Humans; Lithium; Long Term Adverse Effects; Mood Disorders | 2021 |
Venous thromboembolism and severe hypernatremia in a patient with lithium-induced nephrogenic diabetes insipidus and acute kidney injury: a case report.
Topics: Acute Kidney Injury; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Female; Humans; Hypernatremia; Lithium; Middle Aged; Sodium; Venous Thromboembolism | 2022 |
Lithium and endocrine dysfunction.
Topics: Diabetes Insipidus, Nephrogenic; Humans; Hypercalcemia; Hyperparathyroidism; Lithium; Parathyroid Glands; Thyroid Gland | 2022 |
[Diagnostic trap: Lithium neurotoxicity with normal lithemia].
Topics: Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Female; Humans; Hypercalcemia; Lithium; Lithium Compounds; Middle Aged | 2022 |
Central Diabetes Insipidus in the Background of Lithium Use: Consider Central Causes Despite Nephrogenic as the Most Common.
Topics: Adult; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Hypernatremia; Lithium; Polyuria | 2023 |
Iatrogenic endocrine complications of lithium therapy.
Topics: Calcium; Diabetes Insipidus, Nephrogenic; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iatrogenic Disease; Lithium; Lithium Compounds | 2023 |
Tamoxifen Affects Aquaporin-3 Expression and Subcellular Localization in Rat and Human Renal Collecting Ducts.
Topics: Animals; Aquaporin 2; Aquaporin 3; Diabetes Insipidus, Nephrogenic; Dogs; Humans; Kidney; Kidney Tubules, Collecting; Lithium; Rats; Tamoxifen; Ureteral Obstruction | 2023 |
Metabolic reprogramming of renal epithelial cells contributes to lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporin 2; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Kidney; Lithium; Mice; Phosphatidylinositol 3-Kinases | 2023 |
[Lithium-induced nephrogenic diabetes insipidus during acute intoxication: a case report].
Topics: Bipolar Disorder; Dehydration; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Lithium | 2023 |
Partial nephrogenic diabetes insipidus associated with lithium therapy.
Topics: Adult; Amiloride; Antidepressive Agents; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Humans; Kidney Concentrating Ability; Lithium; Male; Osmolar Concentration; Polyuria; Thirst; Treatment Outcome; Water Deprivation | 2019 |
Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporin 2; Bipolar Disorder; Cyclooxygenase 1; Diabetes Insipidus, Nephrogenic; Epithelial Cells; Humans; Kidney; Lithium; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Prostaglandin-Endoperoxide Synthases | 2020 |
Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Topics: Administration, Cutaneous; Aged, 80 and over; Bipolar Disorder; Central Nervous System Depressants; Diabetes Insipidus, Nephrogenic; Diuretics; Ethanol; Female; Humans; Hypercalcemia; Hyperparathyroidism; Lithium; Metals, Alkali; Polyuria; Treatment Outcome; Triamterene | 2021 |
Lithium, an old friend and a forgotten enemy.
Topics: Aged; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Female; Friends; Humans; Lithium | 2020 |
Genetic background determines renal response to chronic lithium treatment in female mice.
Topics: Animals; beta 2-Microglobulin; Biomarkers; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Female; Genetic Background; Immunoglobulin G; Lithium; Mice; Mice, Inbred Strains; Renal Insufficiency, Chronic | 2021 |
Lithium-Induced Nephropathy.
Topics: Cysts; Diabetes Insipidus, Nephrogenic; Humans; Kidney; Kidney Diseases; Lithium; Male; Middle Aged; Osmolar Concentration; Tomography, X-Ray Computed; Urine | 2018 |
Genetic deletion of ADP-activated P2Y
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Dinoprostone; Female; Lithium; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Natriuresis; Potassium; Receptors, Purinergic P2Y12 | 2019 |
Using hypernatraemic events to predict reduced renal function in elderly lithium patients: a brief report.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Case-Control Studies; Diabetes Insipidus, Nephrogenic; Female; Glomerular Filtration Rate; Humans; Hypernatremia; Kidney Failure, Chronic; Lithium; Male; Mental Disorders; Predictive Value of Tests; Prevalence; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2013 |
Evaluation of cellular plasticity in the collecting duct during recovery from lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporin 2; Aquaporin 4; Cell Proliferation; Diabetes Insipidus, Nephrogenic; Forkhead Transcription Factors; Kidney Tubules, Collecting; Lithium; Male; Proton-Translocating ATPases; Rats; Substance Withdrawal Syndrome | 2013 |
Rapamycin inhibition of mTORC1 reverses lithium-induced proliferation of renal collecting duct cells.
Topics: Animals; Antibiotics, Antineoplastic; Antipsychotic Agents; Cell Proliferation; Diabetes Insipidus, Nephrogenic; Drug Evaluation, Preclinical; Kidney Tubules, Collecting; Lithium; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred ICR; Multiprotein Complexes; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy.
Topics: Administration, Oral; Adult; Antidiuretic Agents; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Lithium; Male | 2013 |
Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Topics: Amiloride; Animals; Aquaporin 2; Cells, Cultured; Diabetes Insipidus, Nephrogenic; Epithelial Sodium Channels; Hydrochlorothiazide; Kidney Tubules, Collecting; Lithium; Mice; Sodium Chloride Symporters | 2014 |
Lithium in kidney diseases: big roles for the smallest metal.
Topics: Acute Kidney Injury; Animals; Antimanic Agents; Diabetes Insipidus, Nephrogenic; Female; G2 Phase Cell Cycle Checkpoints; Lithium; Male; Reperfusion Injury | 2014 |
Lithium causes G2 arrest of renal principal cells.
Topics: Animals; Antimanic Agents; Cell Proliferation; Checkpoint Kinase 1; Diabetes Insipidus, Nephrogenic; Female; G2 Phase Cell Cycle Checkpoints; Lithium; Male; Mice; Mice, Inbred C57BL; Protein Kinases | 2014 |
Basic research: the long and the short of it-the temporal effects of renal lithium exposure are beginning to be unravelled.
Topics: Acute Kidney Injury; Animals; Antimanic Agents; Diabetes Insipidus, Nephrogenic; Female; G2 Phase Cell Cycle Checkpoints; Lithium; Male; Reperfusion Injury | 2014 |
Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporin 2; Diabetes Insipidus, Nephrogenic; Homeostasis; Kidney; Lithium; Male; Membrane Transport Proteins; Mice, Knockout; Protein Kinase C-alpha; Protein Transport; Urea Transporters | 2014 |
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Clopidogrel; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Kidney Concentrating Ability; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Purinergic P2Y12; RNA, Messenger; Ticlopidine; Water | 2015 |
4-PBA improves lithium-induced nephrogenic diabetes insipidus by attenuating ER stress.
Topics: Animals; Aquaporin 2; Butylamines; Diabetes Insipidus, Nephrogenic; Endoplasmic Reticulum Stress; Kidney; Lithium; Male; Rats; Rats, Wistar; Treatment Outcome; Urination | 2016 |
Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.
Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Aquaporin 2; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Insipidus, Nephrogenic; Drug Evaluation, Preclinical; Fumarates; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Mice, Inbred C57BL; Polyuria; Prorenin Receptor; Receptors, Cell Surface | 2017 |
Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Diabetes Insipidus, Nephrogenic; Dinoprostone; Fluorescent Antibody Technique; Gene Expression; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Polyuria; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Signal Transduction | 2009 |
Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus.
Topics: Amiloride; Animals; Aquaporin 2; Cell Line; Diabetes Insipidus, Nephrogenic; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Inhibitory Concentration 50; Kidney Tubules, Collecting; Lithium; Male; Mice; Rats; Rats, Wistar; Sodium Channel Blockers; Sodium Channels | 2009 |
Delayed presentation of lithium-induced nephrogenic diabetes insipidus.
Topics: Diabetes Insipidus, Nephrogenic; Diagnosis, Differential; Female; Humans; Lithium; Middle Aged; Time Factors | 2010 |
E3 ubiquitin-protein ligases in rat kidney collecting duct: response to vasopressin stimulation and withdrawal.
Topics: Animals; Antidiuretic Agents; Aquaporin 2; Cell Line; Cullin Proteins; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Endosomal Sorting Complexes Required for Transport; Gene Expression Profiling; Kidney Tubules, Collecting; Lithium; Male; Nedd4 Ubiquitin Protein Ligases; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Ubiquitin-Protein Ligases; Withholding Treatment | 2011 |
[Lithium and its relation with the epithelial sodium channel and aquaporin-2].
Topics: Animals; Antimanic Agents; Aquaporin 2; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Epithelial Sodium Channels; Kidney; Kidney Diseases; Lithium; Lithium Compounds | 2012 |
Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy.
Topics: Adult; Bipolar Disorder; Calcium Channel Blockers; Diabetes Insipidus, Nephrogenic; Female; Gestational Age; Humans; Hypertension; Hypothyroidism; Lithium; Nimodipine; Pregnancy; Pregnancy Complications; Thyroxine | 2002 |
Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI.
Topics: Animals; Diabetes Insipidus, Nephrogenic; Down-Regulation; Epithelial Sodium Channels; Hypertension, Renal; Immunohistochemistry; Kidney Cortex; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Rats; Rats, Wistar; Sodium; Sodium Channels; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1 | 2003 |
Altered expression of renal acid-base transporters in rats with lithium-induced NDI.
Topics: Acidosis; Acids; Animals; Anion Exchange Protein 1, Erythrocyte; Antibody Specificity; Blotting, Western; Carrier Proteins; Diabetes Insipidus, Nephrogenic; Hydrogen-Ion Concentration; Immunohistochemistry; Kidney Cortex; Kidney Tubules, Collecting; Lithium; Male; Membrane Transport Proteins; Proton-Translocating ATPases; Rats; Rats, Sprague-Dawley; Sodium-Bicarbonate Symporters; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sulfate Transporters; Urine | 2003 |
Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI.
Topics: Animals; Antibodies; Aquaporin 2; Aquaporin 4; Aquaporin 6; Aquaporins; Carrier Proteins; Diabetes Insipidus, Nephrogenic; Down-Regulation; Kidney Tubules, Collecting; Lithium; Membrane Transport Proteins; Microscopy, Immunoelectron; Proton-Translocating ATPases; Rats; Rats, Wistar; Recovery of Function; Sulfate Transporters; Urine | 2004 |
Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus.
Topics: Animals; Aquaporin 2; Aquaporins; Diabetes Insipidus, Nephrogenic; Down-Regulation; Gene Expression; Kidney; Kidney Tubules, Collecting; Lithium; Male; Rats; Rats, Wistar; RNA, Messenger; Sodium-Potassium-Exchanging ATPase | 2004 |
Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.
Topics: Animals; Aquaporin 2; Aquaporins; Diabetes Insipidus, Nephrogenic; Diuresis; Drug Administration Schedule; Epithelial Sodium Channels; Hydrochlorothiazide; Lithium; Male; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sodium Channels; Sodium Chloride Symporters; Solute Carrier Family 12, Member 3; Symporters; Up-Regulation | 2004 |
Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Deamino Arginine Vasopressin; Dehydration; Diabetes Insipidus, Nephrogenic; Diabetes Insipidus, Neurogenic; Dinoprostone; Intramolecular Oxidoreductases; Kidney Concentrating Ability; Kidney Cortex; Kidney Medulla; Lithium; Male; Membrane Proteins; Polyuria; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Brattleboro; Rats, Wistar; Renal Agents; Vasopressins; Water Deprivation | 2005 |
Lithium-induced nephrogenic diabetes insipidus.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Female; Humans; Lithium; Polyuria | 2005 |
Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD.
Topics: Aldosterone; Animals; Antimanic Agents; Diabetes Insipidus, Nephrogenic; Epithelial Sodium Channels; Immunohistochemistry; Kidney Cortex; Kidney Tubules, Collecting; Lithium; Lithium Carbonate; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Sodium; Sodium Channels; Spironolactone | 2006 |
Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Topics: Adenylyl Cyclases; Animals; Aquaporin 2; Clone Cells; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Down-Regulation; In Vitro Techniques; Kidney Tubules, Collecting; Lithium; Male; Mice; Rats; Rats, Brattleboro; Rats, Wistar | 2006 |
[Polyuria and polydipsia due to renal diabetes insipidus during the use of lithium].
Topics: Diabetes Insipidus, Nephrogenic; Drinking; Fatal Outcome; Humans; Lithium; Male; Mental Disorders; Middle Aged; Polyuria; Thirst | 2006 |
Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus.
Topics: Amiloride; Animals; Aquaporin 1; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Kidney Medulla; Lithium; Lithium Carbonate; Male; Potassium; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium | 2008 |
Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation.
Topics: Animals; Aquaporin 2; Cell Proliferation; Diabetes Insipidus, Nephrogenic; Down-Regulation; In Vitro Techniques; Kidney Tubules, Collecting; Lithium; Proteins; Proteomics; Rats; Signal Transduction | 2008 |
Hyperosmolar coma and lithium-induced diabetes insipidus.
Topics: Diabetes Insipidus, Nephrogenic; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Lithium | 1995 |
Hyperosmolar coma and lithium-induced diabetes insipidus.
Topics: Diabetes Complications; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Lithium | 1995 |
Hyperosmolar coma and lithium-induced diabetes insipidus.
Topics: Diabetes Complications; Diabetes Insipidus, Nephrogenic; Female; Hemodiafiltration; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Lithium | 1995 |
Hyperosmolar coma and lithium-induced diabetes insipidus.
Topics: Diabetes Insipidus, Nephrogenic; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Lithium | 1995 |
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Down-Regulation; Frozen Sections; Immunoblotting; Immunohistochemistry; Ion Channels; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Microscopy, Immunoelectron; Polyuria; Rats; Rats, Wistar; Water; Water Deprivation | 1995 |
Nephrogenic diabetes insipidus secondary to lithium therapy in the postoperative patient: a case report.
Topics: Adult; Diabetes Insipidus, Nephrogenic; Diuresis; Duodenal Ulcer; Fluid Therapy; Humans; Lithium; Male; Osmolar Concentration; Peptic Ulcer Perforation; Postoperative Complications; Sodium | 1994 |
Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Brain; Diabetes Insipidus, Nephrogenic; Humans; Lithium; Lithium Carbonate; Male; Mood Disorders; Sleep Stages | 1997 |
Persistent nephrogenic diabetes insipidus following lithium therapy.
Topics: Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Diagnosis, Differential; Follow-Up Studies; Humans; Kidney Function Tests; Lithium; Male; Middle Aged | 1997 |
[Polyuro-polydipsia syndrome and renal failure in a patient treated with lithium].
Topics: Aged; Diabetes Insipidus, Nephrogenic; Female; Humans; Lithium; Renal Insufficiency | 1997 |
A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed.
Topics: Adult; Aged; Diabetes Insipidus, Nephrogenic; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lithium; Long-Term Care; Male; Middle Aged; Retrospective Studies; Risk Factors | 2001 |
Lithium-induced nephrogenic diabetes insipidus in older people.
Topics: Aged; Diabetes Insipidus, Nephrogenic; Female; Humans; Lithium | 2001 |
Role of sodium depletion in acute antidiuretic effect of bendroflumethiazide in rats with nephrogenic diabetes insipidus.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Bendroflumethiazide; Benzazepines; Diabetes Insipidus, Nephrogenic; Diuresis; Diuretics; Female; Infusions, Intravenous; Lithium; Rats; Rats, Wistar; Renal Circulation; Sodium; Sodium Chloride Symporter Inhibitors | 2001 |